S-methyl-KE-298
S-methyl-KE-298 is a primary plasma metabolite of KE-298, formed via methylation of deacetyl-KE-298. Its parent compound, KE-298, suppresses MMP-1 production in rheumatoid arthritis synovial cells, indicating its research application in studying RA pathology and metalloproteinase inhibition in vitro.
Product Specifications
CAS Number
143584-75-2
Product Name Alternative
Inhibitor, Matrix metalloproteinases, inhibit, M-2, M 2, MMP-1, MMP, DrugMetabolite, Drug Metabolite, S-methyl-KE 298, SmethylKE298, S-methyl-KE298, S-methyl-KE-298, S methyl KE 298
Field of Research
Metabolism Research, Protein Biochemistry
Purity
96.90% (May vary between batches)
Solubility
DMSO:100 mg/mL (396.31 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (15.85 mM)
Smiles
C (CC (CSC) C (O) =O) (=O) C1=CC=C (C) C=C1
Molecular Formula
C13H16O3S
Molecular Weight
252.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RPC28365-01 20 µg
Recombinant Human Protein mono-ADP-ribosyltransferase PARP14 (PARP14), partial
Sign In for Pricing
View Details RPC28365-02 100 µg
Recombinant Human Protein mono-ADP-ribosyltransferase PARP14 (PARP14), partial
Sign In for Pricing
View Details RPC28365-03 1 mg
Recombinant Human Protein mono-ADP-ribosyltransferase PARP14 (PARP14), partial
Sign In for Pricing
View Details